Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.240
-0.020 (-1.59%)
At close: May 12, 2025, 4:00 PM
1.230
-0.010 (-0.81%)
After-hours: May 12, 2025, 7:35 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $23.38 million as of May 12, 2025. Its market cap has increased by 145.68% in one year.
Market Cap
23.38M
Enterprise Value
9.44M
1-Year Change
145.68%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $23.38M, a decrease of -96.30%. That is a compound annual growth rate of -54.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 23.76M | -30.39% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |